Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)
阿昔替尼联合阿维鲁单抗治疗复发性胶质母细胞瘤：一项分层、开放标签、单中心 2 期临床试验 (GliAvAx)
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-001146
Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart
